Manganese gluconate (CAS NO : 6485-39-8)

Manganese D-gluconate (CAS 6485-39-8) is a critical component in the API intermediates market, primarily used for the synthesis of advanced mineral-based pharmaceuticals and high-performance nutritional supplements that target metabolic and enzymatic deficiencies. As a leading bulk chemical supplier, we have observed that CDMOs are increasingly prioritizing high-purity fine chemicals—typically 99% for Pharma/API and 98% for general industry—to ensure optimal bioavailability and the elimination of heavy metal contaminants in complex formulations. D-Gluconic acid manganese(II) salt (CAS 6485-39-8) has seen a significant uptick in global sourcing as manufacturers seek custom synthesis services that provide robust analytical validation and compliance with USP/FCC standards to meet intensifying regulatory benchmarks. This transition reflects a broader industry movement toward securing reliable, high-performance chemical precursors that stabilize oxidation-reduction processes in both pharmaceutical and specialized industrial applications, such as liquid redox sulfur recovery. Manganous gluconate (CAS 6485-39-8) remains a preferred choice for advanced product development where maintaining precise crystalline morphology and solubility is essential for consistent batch-to-batch reactivity. We are an established global intermediates supplier providing products with 99% or higher purity to ensure minimal impurity carry-over in the final API. Our offering includes a broad range of pharmaceutical intermediates for API manufacturers and finished formulators, supported by comprehensive analytical data such as HPLC, NMR, and MS. We provide essential documentation, including Manganese gluconate COA, TDS, and SDS, along with region-specific regulatory support, reliable lead times, and worldwide supply chain capabilities.